LOCAL-DELIVERY OF VASCULAR ENDOTHELIAL GROWTH-FACTOR ACCELERATES REENDOTHELIALIZATION AND ATTENUATES INTIMAL HYPERPLASIA IN BALLOON-INJUREDRAT CAROTID-ARTERY
T. Asahara et al., LOCAL-DELIVERY OF VASCULAR ENDOTHELIAL GROWTH-FACTOR ACCELERATES REENDOTHELIALIZATION AND ATTENUATES INTIMAL HYPERPLASIA IN BALLOON-INJUREDRAT CAROTID-ARTERY, Circulation, 91(11), 1995, pp. 2793-2801
Background Most strategies designed to reduce restenosis by the use of
pharmacological or biological reagents involve direct inhibition of v
ascular smooth muscle cell (SMC) proliferation. Alternatively, SMC pro
liferation might be indirectly inhibited if reendothelialization could
be specifically facilitated at sites of balloon-induced arterial inju
ry. Accordingly, we investigated the hypothesis that application of an
endothelial cell (EC)-specific mitogen to a freshly denuded intimal s
urface could accelerate reendothelialization and thereby attenuate int
imal hyperplasia. Methods and Results The left carotid artery of 31 Sp
rague-Dawley rats was subjected to balloon injury, after which 16 rats
were treated with a 30-minute incubation with 100 mu g of vascular en
dothelial growth factor (VEGF), an EC-specific mitogen. Control animal
s (n=15) received a 30-minute incubation with 0.9% saline. At 2 weeks
after balloon injury, carotid artery reendothelialization was markedly
superior in the VEGF-treated group compared with the control group (1
4.59+/-1.12 versus 7.96+/-0.51 mm(2), P<.0005). The extent of reendoth
elialization measured at 4 weeks after balloon injury remained superio
r for arteries treated with VEGF (18.04+/-0.90 mm(2)) versus saline (1
3.42+/-0.84 mm(2), P<.005). Neointimal thickening was correspondingly
attenuated to a statistically significant degree in arteries treated w
ith VEGF versus the control group at both the 2-week and 4-week time p
oints. Immunostaining for proliferating cell nuclear antigen (PCNA) di
sclosed a threefold increase in PCNA-positive cells in the neointima o
f control arteries versus VEGF-treated arteries at 2 weeks after injur
y. Conclusions Application of VEGF, an EC-specific growth regulatory m
olecule, may be effectively used in vivo to promote reendothelializati
on and thereby indirectly attenuate neointimal thickening due to SMC p
roliferation.